The scientific programme of the two-day Liver Cancer Summit 2022 provided delegates with a live experience dedicated entirely to primary liver cancers. International experts delivered up-to-date talks on basic, translational, and clinical studies on hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and rare primary liver cancers.